Atrion Corporation 

(Public, NASDAQ:ATRI)   Watch this stock   
Find more results for ATRI

Key stats and ratios

Q3 (Sep '09) 2008
Net profit margin 17.70% 16.34%
Operating margin 26.06% 23.96%
EBITD margin - 30.58%
Return on average assets 14.08% 14.60%
Return on average equity 16.09% 16.82%
Employees 485 -

Address

One Allentown Parkway
Allen, TX 75002
United States - Map
+1-972-3909800 (Phone)
+1-972-3967581 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com

Atrion Corporation discussions

  View all discussions »

Description

Atrion Corporation (Atrion) designs, develops, manufactures, sells and distributes products and components, primarily for the medical and healthcare industry. The Company’s products range from ophthalmology and cardiovascular products to fluid delivery devices. The Company has a line of non-medical components that are sold for use in aviation and marine safety products. The Company also owns and maintains a small gaseous oxygen pipeline that is incidental to the overall operations of the Company.

Officers and directors

Emile A. Battat
Chairman of the Board, Chief Executive Officer
Age: 70
Bio & Compensation - Reuters
David A. Battat
President, Chief Operating Officer
Age: 39
Bio & Compensation - Reuters
Jeffery Strickland
Chief Financial Officer, Vice President, Secretary, Treasurer
Age: 50
Bio & Compensation - Reuters
Hugh J. Morgan Jr.
Director
Age: 80
Bio & Compensation - Reuters
Roger F. Stebbing
Director
Age: 68
Bio & Compensation - Reuters
John P. Stupp Jr.
Director
Age: 59
Bio & Compensation - Reuters
Ronald N. Spaulding
Director
Age: 45
Bio & Compensation - Reuters